ATC code M

From WikiMD's WELLNESSPEDIA

Anatomical Therapeutic Chemical Classification System code for musculoskeletal system drugs

Template:Infobox drug classification

ATC code M is a section of the Anatomical Therapeutic Chemical Classification System (ATC), a system used for the classification of drugs and other medical products. The ATC system is controlled by the World Health Organization (WHO) and is used globally to ensure uniformity in the classification of drugs.

Subgroups[edit]

The ATC code M is divided into several subgroups, each representing a different category of drugs used in the treatment of musculoskeletal conditions. These subgroups include:

M01 – Anti-inflammatory and antirheumatic products[edit]

M02 – Topical products for joint and muscular pain[edit]

  • M02A – Topical products for joint and muscular pain

M03 – Muscle relaxants[edit]

  • M03A – Muscle relaxants, peripherally acting agents
  • M03B – Muscle relaxants, centrally acting agents

M04 – Antigout preparations[edit]

  • M04A – Antigout preparations

M05 – Drugs for treatment of bone diseases[edit]

  • M05B – Drugs affecting bone structure and mineralization
  • M05C – Drugs for treatment of bone diseases

M09 – Other drugs for disorders of the musculoskeletal system[edit]

  • M09A – Other drugs for disorders of the musculoskeletal system

Usage[edit]

Drugs classified under ATC code M are primarily used to treat conditions affecting the musculoskeletal system, including arthritis, gout, osteoporosis, and muscle spasms. These drugs can be administered in various forms, including oral, topical, and injectable formulations.

See also[edit]

References[edit]


{{{1}}}


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.